Explore evidence

5,150 mosquitoesFrom the released mosquitoes, 5150 mosquitoes (2621 males and 2529 females) of An. arabiensis, An. funestus and An. gambiae were recaptured on the attractancy traps.

Kenyapaludismepublished 2023PloS onePubMeddocument of 2 observations

55.7 %The proportion of vitamin D deficiency was 55.7% among HAART-experienced participants.

KenyaVIH/sidapublished 2024BMC infectious diseasesPubMeddocument of 10 observations

20 %Perinatal HIV transmission in Kenya declined from 20% to 10% between 2010 and 2017.

KenyaVIH/sidaobserved 2010 to 2017published 2024PLoS medicineeurope_pmcdocument of 5 observations

41 %The pooled prevalence of persistent respiratory symptoms among individuals who completed treatment for pulmonary TB in low- and middle-income countries was 41.0%.

Kenyapersistent respiratory symptoms · post-TB lung disease · tuberculosepublished 2022PLOS global public healtheurope_pmcdocument of 11 observationsDOI 10.1371/journal.pgph.0000805

38 %In a phase 2b trial in Ghana and Kenya, vaccine efficacy of the RTS,S malaria vaccine against clinical malaria (all episodes) at month 32 post-dose 1 ranged from 38% (95% confidence interval: 24%–49%) to 53% (95% confidence interval: 42%–62%).

Ghana · Kenyapaludismepublished 2024The Journal of infectious diseasesPubMeddocument of 9 observations

24 %Post-training, there was a 24% increase in knowledge scores related to insulin administration.

Kenyadiabetic ketoacidosis (DKA)published 2025BMC medical educationPubMeddocument of 8 observations

76.35 %Anopheles funestus mosquitoes were the predominant vectors at 76.35% of all larvae collections (N = 148).

Kenyapaludismeobserved June 2019published 2025Malaria journalPubMeddocument of 9 observations

7.9 %With an optimal cut-off ≥ 7, the simplified FINDRISC had a positive predictive value (PPV) of 7.9% for detecting undiagnosed diabetes.

Kenyadiabète (non précisé)published 2023PloS onePubMeddocument of 6 observations

65 %Of those screened for PrEP eligibility, 65% of adolescent girls and young women (AGYW) were ineligible.

KenyaVIH/sidaobserved February 2017 to December 2019published 2020Journal of the International AIDS SocietyPubMeddocument of 13 observations

The most common malaria comorbidities were chest infections, diarrhoea, and anaemia.

Kenyaanémie · chest infections · diarrhée · paludismeobserved June 2016 to May 2017published 2021Malaria journalPubMeddocument of 11 observations

37 %At Rota Dispensary, the positivity rate by rapid diagnostic test (RDT) was 37%.

Kenyapaludismepublished 2020Malaria journalPubMeddocument of 17 observations

20 %La fréquence de la neuropathie périphérique était de 20 % chez les personnes vivant avec le VIH au Kenya selon l'étude de Cettomai D et al (2010).

KenyaVIH/sidaobserved 2010HAL · Unilimdocument of 747 observations

0.48 hazard_ratioEarly post-operative infection was associated with delayed healing in both HIV-positive and HIV-negative men (HR 0.48, 95% CI 0.23–1.00).

KenyaVIH/sidapublished 2013PloS oneeurope_pmcdocument of 6 observations

100 %All 67 Cryptococcus neoformans isolates tested were susceptible to amphotericin B, voriconazole, and ravuconazole.

Kenyaméningite cryptococciquepublished 2011Mycoseseurope_pmcdocument of 5 observationsDOI 10.1111/j.1439-0507.2010.01946.x

6,300,000 testsMalaria rapid diagnostic tests showed the highest annual test volumes of 6.3 to 8.0 million in Kenya from 2018 to 2020.

Kenyapaludismeobserved 2018-2020published 2024BMJ openPubMeddocument of 6 observations

8.9 adjusted_odds_ratioDiscontinuing antiretroviral treatment for 2 weeks or more significantly increases the risk of ART failure, with an adjusted odds ratio of 8.9.

KenyaVIH/sidapublished 2017African Journal of Health SciencesOpenAlexdocument of 8 observations

2.09 aPRMale partner controlling behavior was significantly associated with a higher prevalence of intimate partner violence in the past year among women with HIV in serodifferent relationships in Nairobi, Kenya, with an adjusted prevalence ratio of 2.09.

KenyaVIH/sidapublished 2022PloS onePubMeddocument of 8 observations

23.6 %Resistance to isoniazid (INH) among HIV-positive tuberculosis patients in Western Kenya was 23.6%.

Kenyatuberculosepublished 2021BMC infectious diseasesPubMeddocument of 23 observations

7 children7 of the 26 Kenyan children had weak and brief antibody responses to PIESAs.

Kenyapaludismepublished 2003The Journal of infectious diseaseseurope_pmcdocument of 4 observationsDOI 10.1086/373994

1.21 %Hepatitis C virus (HCV) accounted for 1.21% of discarded blood units due to transfusion transmissible infections at the Kwale Satellite Blood Transfusion Centre in Kenya from 2018 to 2022.

Kenyahépatite Cobserved 2018-2022published 2024BMC public healthPubMeddocument of 7 observations

193.3 EU/mLOne month post dose 3, anti-CS geometric mean antibody concentrations were 193.3 EU/mL in RTS,S/AS01-vaccinated HIV-infected children.

KenyaVIH/sidapublished 2020Vaccineeurope_pmcdocument of 7 observations

87.5 %Serious adverse events were reported for 87.5% of HIV-infected children in the C3C group.

KenyaVIH/sidapublished 2020Vaccineeurope_pmcdocument of 7 observations

4.5 %Men in Kenya have an HIV prevalence rate of 4.5%.

KenyaVIH/sidapublished 2025AIDS research and therapyPubMeddocument of 6 observations

39 %Only 39% of individuals with fever in the last two weeks took any action to treat the fever.

Kenyafeverobserved 2009published 2011Malaria journaleurope_pmcdocument of 10 observations

650.6 cells/mm3The median CD4 cell count was 650.6 cells/mm3 among HIV-infected adolescents and young adults aged 10–24 years attending Kenyatta National Hospital comprehensive care center.

KenyaVIH/sidapublished 2021African health sciencesPubMeddocument of 5 observations